Private equity firm H&F considers selling medical device manufacturer Cordis for over $9 billion

Glonghui January 19｜According to Bloomberg, citing people familiar with the matter, US private equity firm Hellman & Friedman is in early talks about a possible sale of medical device manufacturer Cordis, with Cordis valued at more than $9 billion. The report states that around six publicly listed medical device companies are currently evaluating potential bids for Cordis. Six years after Johnson & Johnson sold Cordis, Hellman & Friedman acquired Cordis from Cardinal Health in 2021 for about $1 billion.